7237125

Human Siglec-2/CD22 LlaMABodyTM Bivalent VHH HuIgG2 Fusion Antibody, R&D Systems™

Llama Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

Siglec-2/CD22

Dilution

Immunocytochemistry 8-25 ug/mL

Classification

Monoclonal

Form

Purified

Regulatory Status

RUO

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.

Gene Alias

B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, Siglec2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14

Immunogen

Chinese Hamster Ovary cell line CHO-derived human Siglec-2/CD22 as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody, Asp20-Arg687, Accession # CAA42006.1

Purification Method

Protein A or G purified from cell culture supernatant

Content And Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.

Clone

L007.2.5H

Applications

Immunocytochemistry

Conjugate

Unconjugated

Host Species

Llama

Target Species

Human

Gene Accession No.

CAA42006.1

Gene ID (Entrez)

933

Primary or Secondary

Primary

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Description

  • Siglec-2/CD22 Monoclonal antibody specifically detects Siglec-2/CD22 in Human samples
  • It is validated for Immunocytochemistry